Clinical Trial Detail

NCT ID NCT01063075
Title A Study in Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

Advanced Solid Tumor

Therapies

Carboplatin + Cetuximab + Fluorouracil

Age Groups: adult

No variant requirements are available.